Eric Morgen, M.D.

About Eric Morgen, M.D.

Eric Morgen, MD, MPH, FRCPC, is Co-founder and COO at BioAge Labs, a clinical-stage biopharmaceutical company advancing a broad pipeline of therapeutics to treat and prevent age-related diseases and extend human healthspan and lifespan. BioAge’s computational platform is rooted in longitudinal ‘omics and clinical data spanning more than 40 years and provides a powerful approach to select drug targets that can improve the way we age. Eric’s oversees the company’s clinical, computational, and cohort-based activities.